Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes.

Vasc Health Risk Manag · 2010 · PMC2856574 · PMID 20407626

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

showed a trendP = 0.056so close (0.05 < p ≤ 0.1)

NID showed a trend toward improvement from 13.3% ± 8.0% to 18.9% ± 5.4% ( P = 0.056).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.